Randomized Head-to-Head Comparatison of Pitavastatin, Atorvastatin and Rosuvastatin for the safety and efficacy (Quantity and Quality of LDL)(PATROL study)
- Conditions
- Patients with elevated LDL-C
- Registration Number
- JPRN-UMIN000000586
- Lead Sponsor
- Fukuoka University School of Medicine Department of Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Not provided
1.Familial hypercholesterolemia 2.Uncontrolled diabetic patients defined as HbA1c>8.0% 3.Uncontrolled thyroid disorder patients 4.Severe hepatic disorders or biliary atresia(ALT,AST >= 2 times the upper limit of normal) 5.CK(CPK)>2 times the upper limit of normal 6.Nephrotic syndrome or severe renal disorder defined as serum creatinine >=2.0 mg/dl 7.Myocardial infarction within the previous six months 8.Stroke occurred within six months 9.A history of malignant tumor within 5 years of enrollment or suspicion of present malignancy 10.Patients with a history of hypersensitivity to statins 11.Patients who have ever discontinued administration of study drugs 12.Pregnant and potential pregnancy 13.Patients judged as being inappropriate for the study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method